Comparison between two clomiphene citrate protocols for induction of ovulation in clomiphene resistant Polycystic ovarian disease.

Phase 4

Completed

• Conditions: Reproductive Health and Childbirth - Fertility including in vitro fertilisation; Resistant Anovulation; Polycystic ovarian disease.

• Registration Number: ACTRN12611000639921
• Lead Sponsor: Mervat Sheikh Elarab Elsedeek Omran

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-06-23
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

married, nulligravida, polycystic ovarian disease, resistant to clomiphene citrate drug in previous cycle/s

Exclusion Criteria

previous pelvic surgery, other causes of infertility, BMI>35

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ovulation detected by transvaginal follicle scanning, and serum progesterone value.[after the end of treatment]

Secondary Outcome Measures

Name	Time	Method
chemical pregnancy by serum HCG assay.[after the end of cycle];clinical pregnancy by ultrasonography.[2 weeks after serum pregnancy test.]